Question

A 52-year-old with diabetes and albuminuric CKD (ACR 250 mg/g; eGFR 55) is on ACE inhibitor and metformin. According to ADA/KDIGO-aligned guidance, which addition is indicated to slow CKD progression and reduce CV events?

Accepted Answer

SGLT2 inhibitor

Answer

DPP-4 inhibitor

Answer

Thiazolidinedione

Answer

Sulfonylurea

Answer

Basal insulin

Practice question

A 52-year-old with diabetes and albuminuric CKD (ACR 250 mg/g; eGFR 55) is on ACE inhibitor and metformin. According to ADA/KDIGO-aligned guidance, which addition is indicated to slow CKD progression and reduce CV events?